Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The calcium-containing replacement solution is a specialized electrolyte formulation developed by the Nephrology Department at West China Hospital, Sichuan University, for use in Continuous Renal Replacement Therapy (CRRT). It is specifically designed to facilitate regional citrate anticoagulation (RCA) by incorporating calcium directly into the replacement fluid. In traditional RCA protocols, calcium is typically omitted from the replacement fluid and infused separately to prevent clotting within the extracorporeal circuit while maintaining systemic calcium levels. This modified solution simplifies the CRRT procedure by eliminating the need for a separate calcium infusion pump, thereby reducing the complexity of the circuit and the risk of dosing errors. It is primarily indicated for patients with acute kidney injury (AKI) or end-stage renal disease (ESRD) who require extracorporeal blood purification with citrate anticoagulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium-containing replacement solution.